|
Researchers
Find New Way to Control or Enhance Stem Cells’ Fusion Process
By Gail
Gallessich
The discovery was made in the laboratory of Joel
H. Rothman, professor of molecular, cellular, and developmental
biology, and described in a paper in the May issue of the journal
Developmental Cell.
Rothman explained that cell fusion is analogous
to the melding of soap bubbles, and the process is involved in creating
many human tissues, including muscles, bones, and placentas. “When
a cell fuses with others, it loses its individuality,” said Rothman.
“But it can also adopt a new career, either productive, as when
stem cells regenerate organs, or sinister, as in cancer metastasis.”
The discovery by Rothman and his co-authors reveals
that inappropriate fusing of cells is naturally prevented by a familiar
protein, called vacuolar ATPase, acting in an entirely unanticipated
context. The discovery suggests new avenues for pharmaceutical companies
to develop drugs to enhance organ regeneration by stem cells, prevent
cancer progression, and control fertility.
Vacuolar ATPase was known to make certain compartments
inside a cell become more acidic, an essential function in cell
biology. Now it is understood that the protein also works on the
surface of the cell to prevent cell fusion.
“The protein is in an unexpected place, doing an
unexpected job,” said Rothman. “This finding might make it possible
to develop new methods, and new drugs, for controlling cell fusion.”
In addition to Rothman, the other authors are: Kenji Kontani (first
author) who has moved on to the University of Tokyo, Japan, and
Ivan P.G. Moskowitz now at Harvard University.
The new discovery makes known a protein that prevents
cell fusion from happening inappropriately. “It’s as if we now have
a yin and yang of cell fusion,” he said.
|